LISA SCHOLL: Open Payments
NPI 1184867541 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$830 in 11 payments from 7 companies in 2025. Trend: 2023 $2,467 · 2024 $605 · 2025 $830
Food & beverage: $830
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $182 |
| Amgen Inc. | 1 | $139 |
| Incyte Corporation | 1 | $125 |
| Stemline Therapeutics Inc. | 1 | $125 |
| Genmab U.S., Inc. | 1 | $123 |
| Exelixis Inc. | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $14 |
Products named: KEYTRUDA, IMDELLTRA (AMG757), Niktimvo, Orserdu, Epkinly, CABOMETYX, Trodelvy.
Industry payments across TN — which companies pay providers there.
